Featured Research

from universities, journals, and other organizations

UK women scientists have fewer studies funded, given less money than men

Date:
December 9, 2013
Source:
BMJ-British Medical Journal
Summary:
Women scientists specializing in infectious disease research have fewer studies funded than men, and receive less funding across most topic areas in the specialty than their male peers, finds a study published.

Women scientists specializing in infectious disease research have fewer studies funded than men, and receive less funding across most topic areas in the specialty than their male peers, finds a study published in the online journal BMJ Open.

Related Articles


These gender discrepancies have remained broadly unchanged for more than a decade, the findings show.

Attempts should be made to explore the reasons behind these differences, particularly in light of the fact that the UK government is committed to boosting the number of women choosing a career in science, say the study authors.

They base their findings on an analysis of funding awards made to UK academic institutions for all infectious disease research from 1997 to 2010. They included all disease categories; public and philanthropic funders; and all phases of the research and development pipeline.

Some 6052 studies were included in the final analysis, worth a total of 2.274 billion in grants. Almost three quarters of these (72%, 4357) were awarded to men, with the remainder (28%, 1695) awarded to women.

And men got most of the total investment, clocking up 1.786 million (78.5%), while women got 488 million (21.5%). Women's total share ranged from just over 14% in 1998 to just under 27% in 2009.

Analysis of the sums awarded to individual research projects showed that women also received substantially less money than men did. The average value of a grant awarded to men was 179,389 compared with 125,556 for women.

Male lead researchers (principal investigators or PIs for short) were awarded more than their female counterparts across all topic categories in the specialty, with the exception of neurological and sexually transmitted infections.

Women got the smallest share of total funding for the earliest phase of research and development (pre-clinical research) -- at just over 18% -- and got the largest (for them) for the latest phase (operational research) -- at just under 31%.

The authors emphasize that they were unable to assess the success and failure rates of grant applications by gender, and so can't draw any conclusions about potential inherent bias.

Similarly, they didn't know the seniority of the lead researcher in each of the studies so couldn't tell whether there were more men than women scientists at senior level leading research projects and seeking funding. This might explain some of the discrepancy.

But previous research indicates that there are significant gender differences in the amount of funding awarded, even after taking account of the seniority of the principal investigator.

The authors comment that the differences in research funding awarded by gender are "substantial," and that these differences are "clear and consistent."

They write: "Women received less funding in absolute amounts and in relative terms, by funder and the type of science funded along the R&D pipeline. These differences in funding between men and women persist over time."

And they conclude: "We strongly urge policy-makers, funders and scientists to urgently investigate the factors leading to the observed differences and develop policies to address them, in order to ensure that women are appropriately supported in scientific endeavor."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. G. Head, J. R. Fitchett, M. K. Cooke, F. B. Wurie, R. Atun. Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997-2010. BMJ Open, 2013; 3 (12): e003362 DOI: 10.1136/bmjopen-2013-003362

Cite This Page:

BMJ-British Medical Journal. "UK women scientists have fewer studies funded, given less money than men." ScienceDaily. ScienceDaily, 9 December 2013. <www.sciencedaily.com/releases/2013/12/131209204110.htm>.
BMJ-British Medical Journal. (2013, December 9). UK women scientists have fewer studies funded, given less money than men. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2013/12/131209204110.htm
BMJ-British Medical Journal. "UK women scientists have fewer studies funded, given less money than men." ScienceDaily. www.sciencedaily.com/releases/2013/12/131209204110.htm (accessed November 1, 2014).

Share This



More Science & Society News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

EU, Russia, Ukraine Seal Breakthrough Gas Accord

EU, Russia, Ukraine Seal Breakthrough Gas Accord

AFP (Oct. 31, 2014) Russia agrees to resume gas deliveries to war-torn Ukraine through the winter in an EU-brokered, multi-billion dollar deal signed by the three parties in Brussels. Duration: 01:10 Video provided by AFP
Powered by NewsLook.com
Alcoholic Drinks In The E.U. Could Get Calorie Labels

Alcoholic Drinks In The E.U. Could Get Calorie Labels

Newsy (Oct. 31, 2014) A health group in the United Kingdom has called for mandatory calorie labels on alcoholic beverages in the European Union. Video provided by Newsy
Powered by NewsLook.com
Relief After “gas War” Is Averted

Relief After “gas War” Is Averted

Reuters - Business Video Online (Oct. 31, 2014) A gas war between Russia and Ukraine has been averted. But as Hayley Platt reports a deal was only reached after Kiev's western creditors agreed to partly funding the deal. Video provided by Reuters
Powered by NewsLook.com
Malaria Threat in Liberia as Fight Against Ebola Rages

Malaria Threat in Liberia as Fight Against Ebola Rages

AFP (Oct. 31, 2014) Focus on treating the Ebola epidemic in Liberia means that treatment for malaria, itself a killer, is hard to come by. MSF are now undertaking the mass distribution of antimalarials in Monrovia. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Science & Society

Business & Industry

Education & Learning

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins